...
【24h】

Dick Tracy, APRN

机译:迪克·特雷西,APRN

获取原文
获取原文并翻译 | 示例

摘要

The aim of our study is to investigate the long-term transitions of intraocular pressure (IOP) and aqueous flare values in uveitis patients with faint anterior chamber flare who were treated with once-daily topical ophthalmic betamethasone for more than 6 months. The study included a total of 111 eyes of 68 outpatients. The mean follow-up period was 26.8 months. The average IOP and aqueous flare value of patients divided by the 5-months follow-up period showed no significant difference. Six eyes (of four patients) were followed-up for more than 1 year after termination of the treatment. Among these patients, the average aqueous flare value was significantly higher, and the average period to reach more than 1.5 times the former aqueous flare value significantly decreased after termination than before. Once-daily topical ophthalmic betamethasone is not expected to cause steroid-induced ocular hypertension but to have prophylactic effect.
机译:我们研究的目的是调查每天一次局部用眼用倍他米松治疗超过6个月的葡萄膜炎伴前房暗淡的葡萄膜炎患者的眼内压(IOP)和房水耀斑值的长期变化。该研究共纳入68位门诊患者的111只眼。平均随访期为26.8个月。患者的平均眼压和房水耀斑值除以5个月的随访期无显着差异。治疗终止后,对六只眼(四名患者)进行了一年以上的随访。在这些患者中,平均房水耀斑值明显更高,终止后平均达到前房水耀斑值1.5倍以上的平均时间显着缩短。每天一次的局部眼用倍他米松预计不会引起类固醇诱发的高眼压,但具有预防作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号